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Abstract
Sickle cell anemia is a serious disease with manifestations and complications that
directly affect the patient’s quality of life and his entourage. This is not a shameful
disease on the contrary; it is linked to a mutation that arose for us to defend against
severe forms of malaria. It is due to the so-called selective pressure that has enabled
AS carriers to resist severe forms of malaria. This advantage explains among other
things why, although cosmopolitan, sickle cell disease predominates in Africa and
its geographical distribution is superimposed on the malaria one. In the Democratic
Republic of the Congo (DRC), it is estimated that there are 25–30% heterozygous
healthy carriers (AS) and about 50,000 homozygous newborns (SS) each year,
equating to 2% of newborns. Therefore, an effective medical care is very indispens-
able. The management of any pathology implies the appropriate choice of
techniques and technologies. Unfortunately, very often in sub-Saharan countries,
there is a lack of global strategy to providing effective solution. The choice of
equipment performed after an objective needs analysis enables to optimize the
acquiring process, to ensure the quality of reported results, and to provide more
accessible costs to target populations that are generally poor. Biomedical engineers
may enhance health by assessing and managing health technologies.
Keywords: sickle cell anemia, project management, biomedical equipment,
planning
1. Introduction
By way of introduction, the quotation below significantly translates the problem
of sickle cell disease both in the Democratic Republic of the Congo and in most
countries of sub-Saharan Africa:
“Sickle cell disease is a genetic inherited disorder where hemoglobin (Hb) normal A
(HbA) is replaced by another abnormal, HbS.”
Sickle cell anemia is a serious disease with manifestations and complications that
directly affect the patient quality of life and his entourage. This is not a shameful
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disease contrary; it is linked to a mutation that arose for us to defend against severe
forms of malaria. It is due to the so-called selective pressure that has enabled AS
carriers to resist severe forms of malaria. This advantage explains among other
things why, although cosmopolitan, sickle cell disease predominates in Africa and
its geographical distribution is superimposed on the malaria one.
There are four major outbreaks of sickle cell disease based on genetic markers called
haplotypes: Arabo-Indian, Beninese, Senegalese, and Central African or Bantu.
Among Bantu haplotype carriers, the clinical expression of the sickle cell disease is
more severe because of, among other things, the relatively low rate of the fetal
hemoglobin (HbF) and other genetic factors.
According to WHO estimates, approximately 300–500,000 children are born
each year with hemoglobinopathy; 80% of them are born in developing countries,
particularly in Africa. The sickle cell anemia is a hemoglobin disorder most common
in Africa, where every year about 200,000 newborns with sickle cell disease are
diagnosed and 80% will not reach the age of 5 years.
In the Democratic Republic of the Congo (DRC), it is estimated that there are
25–30% heterozygous healthy carriers (AS) and about 50,000 homozygous newborns
(SS) each year, equating to 2% of newborns [1].
Sickle cell disease is particularly common among people from sub-Saharan
Africa, India, Saudi Arabia, and Mediterranean countries. Migration has increased
the frequency of the offending gene in the Americas. In parts of sub-Saharan Africa,
sickle cell disease affects up to 2% of newborns. More broadly, the prevalence of
sickle cell disease (healthy carriers that inherited the mutant gene from only one
parent) in equatorial Africa is 10–40%, compared to only 1–2% on the coast of
North Africa and less than 1% in South Africa. This distribution reflects the fact that
the sickle cell trait confers an advantage in terms of survival against malaria and
that the selection pressure due to malaria has made the mutant gene more frequent,
especially in areas with high malaria transmission. In West African countries such
as Ghana and Nigeria, the rate of trafficking is 15–30%, while in Uganda, where
marked tribal variations are observed, it is 45% among the Bahamas of west of the
country [2].
2. Problems of financing of health systems and their corollary in the DR
Congo
2.1 Deficit in sources of health-care funding
A country’s problem of access to health care depends on its ability to finance the
required health systems. This presupposes that the country concerned can offer
structures, viable infrastructures, and competent personnel. However, low-income
countries are struggling to find adequate budget balances to effectively meet the
ever-growing health needs of their populations [3], and this is the case of the DR
Congo and many other countries in sub-Saharan Africa.
Indeed, the current sources of financing useful for universal health coverage are
essentially public expenditure, donor funding, and compulsory contributions to
social health insurance [4]. Since under current conditions household contributions
to health care remain relatively low, with a few exceptions when community initia-
tives are organized [5] or when the state is effectively involved, only two sources
are secure: public spending and donor funding.
With regard to public expenditure, the state budget is low, often well below
Abuja’s commitments (15%) [6]. In 2013, for example, the Congolese state allocated
only 4.3% of its budget to health, while all projections for spending in 2020 are
below 3%. Worse still, this state contribution has only decreased from 2013 to date.
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It just so happens that a large part of the financing of the health system relies
heavily on donor funding. And in order to cover all needs, donors will theoretically
have to continually increase their contribution in proportion to the decrease in the
state budget.
But is such a hypothesis sustainable? Logically, the answer is negative, since
donors cannot set themselves up as substitutes for failing health systems. Indeed,
the study of the financing mechanism supported by the World Bank Group shows
that “the health sector in the DRC suffers from several ills: low budget allocation;
excessive household expenditure; dependence on external financing; available
resources are poorly spent; budget execution is weak; governance problems; and the
decentralization process is partly theoretical.” [7] The same study shows that a
decrease in external financing is observed from 2017, just as the projections predict
that the deficit financing observed since 2019 will have to continue until 2030.
2.2 Attempt to address the funding gap for the management of sickle cell
disease
In the specific case of the management of sickle cell disease, are there other ways
of compensating for this financial situation?
The first way already present in the field is that of the actions of charitable
associations. The contribution of several nongovernmental organizations involved
in the management of specific pathologies such as sickle cell disease is very signif-
icant and constitutes a major support, especially for the most deprived populations.
The action is perceptible not only in the DR Congo but also in other countries of
sub-Saharan Africa [8]. But these efforts remain insignificant compared to the
magnitude of the disease, and a country’s health policy cannot be based on impulses
that are difficult to predict.
The second way is the frequent use of donated second-hand equipment to
reduce the costs they (the equipment) represent in the health-care chain. This
resource can make a great contribution if best practices for donors and donors’
applicants are rigorously observed [9]. Unfortunately, very often this is not the
case. Many donations still arrive in Africa without observing the prerequisites,
which very often makes them either ineffective or unusable. On the other hand,
recourse to donations of second-hand equipment should remain ad hoc, without
becoming structural.
The third way is that of optimizing the use of the means available to approach
the objectives set. At the international level, donors have understood the challenge
of structured and well-executed health financing. This obliges the partners to
accompany for decades the countries receiving aid through specific national
programs in order to reduce deficits and achieve the objectives.
In the DR Congo, it is through the national health development program that the
government and its partners express their willingness to provide effective and
realistic solutions to the health problems of the DR Congo’s populations. This is
generally applied for a period of 5 years, iteratively after evaluation.
The partners in the health field remain practically the same for African coun-
tries, and their health problems are very similar: the fight against epidemics, mal-
nutrition, and hereditary diseases. This probably explains why almost all countries
in sub-Saharan Africa each develop a national health development plan, with virtu-
ally the same content except for a few differences. Examples include the DR Congo,
Mali, Côte d’Ivoire, Burkina Faso, Benin, and Kenya. Therefore the methods applied
by the partners for health support to the different countries will be very similar.
In the national health development plans drawn up in many sub-Saharan African
countries since 2000 to date, the improvement of infrastructures and the strength-
ening of the capacities of the medical technical platforms, including the expression of
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needs, acquisition, and maintenance of the systems acquired, are among the issues
addressed. These topics involve a lot of money that will have to be put to good use;
otherwise they can be a source of conscious or unconscious waste of scarce resources.
In the case of the DR Congo, a reflection carried out on the medical technical
platform shows that the objectives assigned to medical infrastructure and equipment
through national programs are never achieved and the situation is getting more
complicated every year. And yet, after evaluation, the same programs continue with
the same objectives and use practically the same methods [10]. In order to minimize
procurement costs, the WHO proposes a strategic procurement approach to achieve
universal health coverage [11]. The illustration below is more explicit.
This diagram raises fundamental questions that need to be answered if we are to
succeed in our efforts. Indeed, countries cannot simply spend their money on
universal health coverage. They must master purchasing, define the relationships
between suppliers and buyers, define a purchasing strategy on the basis of useful
data before disbursement, and finally move from passive purchasing to strategic
purchasing.
The fourth path, a corollary to the third, consists of mobilizing and structuring
human skills, each in its own sector, to boost the strategic purchasing process. Since
the problem of strategic purchasing concerns all sectors, what can the biomedical
engineer’s contribution be as far as it is concerned?
From this point of view, the biomedical engineer can play an important role as
a technical interface between the hospital, suppliers, and industry to make the
right choices, as he is considered responsible for the research and development,
architecture, selection, management, and safe use of all types of medical devices
including single-use, reusable, prosthetic, implantable, and bionic devices, among
others [12].
For several decades, a developed country like France has been efficiently
involving biomedical engineers in the medical equipment procurement process
[13]. It organizes hospital purchasing, where biomedical engineers play a leading
role in the purchasing function that has developed in companies over the last 30
years or so [14]. Better still, it is developing a purchasing policy that, among other
things, brings together the skills of biomedical engineers to offer end customer
equipment negotiated at attractive prices through group purchasing [15].
But in the Democratic Republic of the Congo in particular and in sub-Saharan
Africa in general, the biomedical engineering component does not seem to be
sufficiently integrated at its best in the administrative and technical response
mechanisms for improving health care. This aspect of things can only lead to a
waste of funds when the actors at this stage do not master the equipment.
3. Situation of medical equipment dedicated to the analysis of
hemoglobinopathies
In the field there are currently different types of electrophoresis equipment.
However, to date, it is difficult to determine their number, origins, and brands,
4
Human Blood Group Systems
given the country’s size, diverse supply methods, and ineffective control
mechanisms. Nevertheless, some facilities stand out from the others in terms of
their number, mainly for historical and geographical, economic, and commercial
reasons.
Historically and geographically, sickle cell disease was first discovered in black
populations in Africa and in the Arabian Peninsula; to date it remains more frequent
in these geographical areas. Initially, this disease, which later turned out to be
hereditary, did not directly affect the Indo-European populations.
However, due to massive immigration, countries with well-organized preven-
tion programs are now faced with the problems of uninformed couples of
allochthonous origin, as well as variations in specific population characteristics,
which is rare among indigenous populations [16].
In the early 1970s, screening tests were launched in the United States, and the
American population of African origin was indeed very affected. In 1981, an exper-
imental neonatal screening program began in the French Antilles and metropolitan
France. It is set up by the Association Française pour le Dépistage et la Prévention
du Handicap (AFDPHE). It was only in 2000 that neonatal screening for sickle cell
disease was, this time, extended in whole France [17].
As a result of the above, electrophoresis systems are initially more equipped with
routine programs dedicated to serum protein analysis; programs for the analysis of
hemoglobinopathies will gradually come into operation. Indeed, the implementa-
tion of new programs involves significant costs that the manufacturer cannot incur
without a guaranteed return on investment.
Since the greatest need for sickle cell disease management is in Africa, countries
with strong historical ties to the continent will find it easier to sell their technologies
to this potential market. Among them we will mention the most prominent firms
such as HELENA, TITAN, BECKMAN SEBIA, and BIORAD.
In financial terms, the choice of equipment for routine needs will focus more on
technical solutions that offer good results at lower cost. From this point of view, for
the analysis of hemoglobinopathies, there is an established correlation between
agarose gel electrophoresis on the one hand and capillary electrophoresis on the
other [18]. On the other hand, high-performance liquid chromatography (HPLC)
and capillary techniques are complementary and can be used routinely, knowing
that capillary diagrams are easier to read and interpret than those obtained in HPLC.
Even better, the development of the capillary technique for the characterization of
hemoglobin variants suggested that it would become the first method of choice for
screening in many clinical laboratories [19].
This trend is confirmedwith regular innovations from certainmanufacturers, and
this is the case of SEBIA,which has added to its range for the screening of hemoglobin-
opathies [20]. In addition, the capillary technique ismore sensitive than theHPLC
technique for the detection of certain variants such as hemoglobinNewYork [21].
On the commercial level, thanks to their historical links with Africa, the first
companies are more easily organized and set up local representations of their firms
to facilitate the sale of their products. Among the first to obtain country-level
representation are HELENA and BECKMAN.
But for almost two decades, we have been observing the rise of the SEBIA com-
pany, which offers different models of equipment according to the needs and which
regularly innovates its products. Today, this firm, now a world leader in the field of
electrophoresis, is among those with a large number of distributors in Africa.
Apart from the abovementioned brands, it is worth noting a slow penetration of
products of Asian origin in the field. However, while the financial offer is attractive,
distribution is still struggling to be structured in terms of regularity, reliability, and
operation.
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In the present case of the management of sickle cell disease and in order to make
his contribution relevant and effective, the biomedical engineer must make an
inventory of the existing situation in the field, evaluate the technologies in the state
of the art, and propose material solutions that present a better compromise between
technical and technological contributions and optimization of the financial aspect.
4. Analysis of onboard techniques on electrophoresis systems
The following theories are drawn mainly from the book Appliances and Methods
in Biochemistry and Molecular Biology, whose pedagogical approach seems clearer.
4.1 General principles of electrophoresis
Electrophoresis has established itself over time as the method of choice for the
qualification and quantification of different fractions in the management of hemo-
globinopathy. It involves methods often embedded in laboratory materials. We
review below the most common methods in electrophoresis of hemoglobin.
4.1.1 Definitions
Electrophoresis is a physical method of separating molecules based on their
difference in mobility, under the effect of an electric field. Zone electrophoresis,
carried out on a solid support, is used to essentially separate the ionizable biological
macromolecules, that is to say proteins, nucleic acids, and certain polyosides and
proteoglycans.
Liquid vein electrophoresis, currently capillary electrophoresis, is also applied to
small molecules, organic or mineral, and not necessarily ionizable. In the most
common case, the movement of the molecule depends on several intrinsic (due to
the molecule itself) and extrinsic parameters, in particular linked to migration
buffers which play the role of solvent [22].
4.1.2 Zone electrophoresis
This is the electrophoresis whose migration medium is stabilized by a real or
sometimes virtual porous support as in the density gradient. In the case of a porous
substrate, it is soaked with a buffer solution that both ensures conductivity and
stabilizes the pH at the desired value. The molecules separate according to their
different mobility in the system (they appear as migration zones) and will be
visualized in a second time (“revelations”); we can even isolate them from the
support for the preparatory purpose.
Zone electrophoresis is mainly applied to the separation of macromolecules.
4.1.2.1 Characteristics
These electrophoreses are often characterized by strong electroosmotic currents
and sometimes intense Joule effect. The most common electroosmotic current is the
electroendosmosis current, especially in polyosidic supports used at pH alkaline: the
walls are negatively ionized as the macromolecules to be separated; positive buffer
charges are attracted to the cathode and create a current that is in the opposite
direction of electrophoretic migration.
Another electroosmosis phenomenon is related to the structure of the support,
which can be assimilated to a capillary network; the friction forces are greater on the
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edges of the support, and the center moves faster, distorting the migration band.
Finally, the Joule effect heats the substrate and therefore evaporates the solvent; this
is gradually replaced by the liquid of the vessels which rises in the support by
capillary action, opposite both ends of the support, and annulling in the middle [23].
4.1.2.2 Supports
The supports must be chemically inert (low adsorbent) and homogeneous (reg-
ular microporous structure), have good mechanical resistance (handling), and
possibly allow densitometric reading [24].
4.1.2.2.1 Paper
Paper is a natural cellulose; it is no longer used much because it is not homoge-
neous. Paper electrophoresis provides a strong electroendosmosis current and is a
source of parasitic adsorptions (added chromatography), resulting in poor resolu-
tion; the Joule effect is important with heating, evaporation, and even electrolysis of
the buffer. At high pressure (1000–3000 V), paper electrophoresis is mainly used to
separate peptides and amino acids.
4.1.2.2.2 Cellulose acetate
Cellulose acetate is much more homogeneous than paper; this support allows
densitometric reading, but the electroendosmosis current remains high. The appli-
cations of cellulose acetate are mainly found in medical biology, allowing a quanti-
tative densitometric reading of the protein fractions rather roughly separated
(plasma and urinary proteins, lipoproteins, and hemoglobins), or finer (isoen-
zymes), applying the potential gradients of the order of 30 V cm1. Resolution is
poor, and reproducibility is average.
However, at alkaline pH (typically pH 8.6), Hb A2, Hb C, Hb E, and Hb O
migrate to the same area, and Hb S, Hb D, and Hb G migrate at the same rate. In the
case of suspicions of such hemoglobin abnormalities, an additional technique should
therefore be considered [25].
4.1.2.2.3 Starch gel (cross-linked starch)
Starch gel is a polyoside; electrophoresis on this gel allows the separation of
complex or heterogeneous oligomeric protein associations. Starch gel is little used
because it is opaque, fragile, and not very reproducible.
4.1.2.2.4 Agarose gel
Agarose is desulfonated agar (purified agar); removal of sulfonates greatly limits
the flow of electroendosmosis; agarose gels between 0.5 and 2% are not very vis-
cous. They make it possible to carry out native electrophoresis as with the previous
supports, that is, without denaturation of the macromolecules. Potential gradients
up to 50 V cm1 are usable for protein separation; agarose gel is gradually replacing
cellulose acetate in most biomedical applications because agarose improves resolu-
tion and remains colorless, allowing a good densitometric reading. The agarose gel is
also very homogeneous, thus ensuring good reproducibility, and is well adapted to
zymographic reading [23].
The distinction between the different variants Hb A2, Hb C, Hb E, and Hb O, as
well as Hb S, Hb D, and Hb G, is most often made by electrophoresis on agarose gel
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at acidic pH (pH 6.0), which allows to separate Hb C, from Hb E and Hb O, as well
as Hb S, from Hb D and Hb G. On the other hand, Hb E and Hb O, as well as Hb D
and G, still cannot be differentiated by combining these two electrophoretic
methods (cellulose acetate, agarose gel). In addition, these techniques have the
disadvantage of consuming time and labor.
In addition, they lack precision for the quantification of hemoglobin in low
concentrations, such as Hb A2, and for the detection of fast-migrating variants,
such as Hb H or Hb Bart’s. It is even now accepted that the quantification of variants
by densitometry lacks precision and that these two electrophoresis techniques must
be used for qualitative purposes. They are therefore most often used today in
combination with another method, mainly high-performance liquid chromatogra-
phy, which has a much higher accuracy.
A 1999 study by the College of American Pathologists showed a coefficient of
variation (CV) of 33.6% for the quantification of Hb A2 at a concentration of 2.41%
by densitometry from electrophoretic gels. By HPLC, the CV was 4.3% for Hb A2 at
a concentration of 3.47%. Thus, the combination of these electrophoresis techniques
with HPLC allows the identification and quantification of hemoglobin, the latter
being performed by HPLC only [26].
4.1.2.2.5 Polyacrylamide
It is a polymer of acrylamide and N,N0-methylene-bisacrylamide (Bis), the
acrylamide gel polymerization being obtained in the presence of a catalyst (ammo-
nium persulfate) and a cross-linking agent (N,N,N0,N0-tetramethyl-ethylene-
diamine [TEMED]). The porosity of gels can be very precise; it depends on the
relative concentrations of acrylamide and Bis.
The polymer obtained is very hydrophilic although insoluble in water and easy
to mold even under small thicknesses (<1 mm); it is thermostable, not fragile,
transparent, and inert chemically. There is almost no electroendosmosis flow and no
macromolecules are absorbed. The resolutive power is generally superior to that of
polyosidic gels using gradients of similar potential. The main disadvantage is that
the acrylamide in solution is neurotoxic but also that the resulting porosities are
very poorly adapted to very large molecules [27].
4.1.2.3 Zone electrophoresis methods
4.1.2.3.1 Native electrophoresis (without denaturation)
It is made on paper, starch, cellulose acetate, agarose gel, and sometimes poly-
acrylamide whenever we do not want to touch the tertiary and quaternary struc-
tures of macromolecules, thus their biological activities. This method without
denaturation is a priori applicable to all types of macromolecules, both in vertical
and horizontal tanks [27].
4.1.2.3.2 Isoelectrofocusing
Isoelectrofocusing, carried out on agarose gel or polyacrylamide gel, separates
hemoglobin in a pH gradient according to their isoelectric point. To do this,
ampholytes are introduced into the gel in order to create a continuous pH gradient
under the effect of an electric field. The different hemoglobins contained in the
sample to be analyzed will migrate to the region where the pH is equal to their
isoelectric pH. At this position, the net load is zero, and the hemoglobin ceases to
migrate and focuses into a narrow band.
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This technique, capable of separating hemoglobin variants with isoelectric
points different from 0.02 pH units, has excellent resolution and is very useful for
detecting abnormal hemoglobin in the newborn. In fact, it allows a good separation
of hemoglobins F, A, and S. Moreover, the electrical isofocusing is perfectly adapted
to the analysis of large series. On the other hand, the main limitations of this
method are a long and complex implementation. Therefore, its use is almost
reserved for neonatal screening of hemoglobinopathies [28, 29].
4.1.3 Liquid vein electrophoresis
4.1.3.1 Characteristics
Typically, capillary electrophoresis is performed in a fused silica capillary coated
with a polyamide layer of 20–200 μm of internal diameter and 20–200 cm of length.
The capillary, placed in a thermostatization system, is filled with a buffer solution
and plunges into two tanks containing the same solution. Each tank is connected to
an electrode connected to a current generator. A large potential difference (several
thousand volts) is applied to the terminals of each capillary to separate the
molecules on the basis of their charge/mass ratio [30].
The use of a capillary has a double advantage: increases the sensitivity of the
detection since a reading window in the capillary allows an absorbance reading with
a very small optical path and increases the resolution by applying the potential
difference of more than 10,000 V since it is easy to regulate the capillary in
temperature [31].
4.1.3.2 Support
In this method, the buffer solution in contact with the two tanks of the system
constitutes the support. Since liquid has no specific form, the buffer uses the capillary
as a solid support, contributing also to electroendosmosis current production.
4.1.3.3 Liquid vein electrophoresis methods
There are several methods used in capillary electrophoresis including capillary
zone electrophoresis (CZE), capillary gel electrophoresis (CGE), and micellar elec-
trokinetic chromatography (MECC) [32]. In this study, we will limit ourselves to
capillary zone electrophoresis which is the most exploited for hemoglobinopathy.
This method can be performed on a single-fused silica capillary in which an
electroosmotic flux develops. It causes the negative molecules to the cathode where
the detection is carried out, the injection being anodic.
The electroosmotic flux depends on the temperature, the ionic force, and the
concentration of organic solvent.
4.2 Facilities
We will limit ourselves here to the most common routine techniques for the
analysis of hemoglobinopathies in the Democratic Republic of the Congo in
particular and in sub-Saharan Africa in general. They are often affected by accessi-
bility during acquisition, ease of commissioning, operation, maintenance and
supply, and cost.
On one side, our analysis is based globally on equipment meeting international
standards such as ISO, FDA, and CE certification. Field experience shows that such
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equipment can operate for about 7 years, if the manufacturer’s operating recom-
mendations are followed.
On the other hand, high-performance liquid chromatography has been developed
to allow both the detection and confirmation of hemoglobinopathy in newborns with
high sensitivity and specificity. In fact, its good sensitivity to the major variants
involved in pathology and its speed of completion (about 3 min per sample), allowing
the analysis of a large number of samples, have made HPLC a particularly suitable
method for screening for hemoglobin abnormalities [33].
However, we will not discuss this technique in this study because, since its
performance is comparable to that of the HPLC method, capillary electrophoresis
quickly became the method of choice, just like HPLC, for the study of hemoglobin-
opathy. In addition, it is of economic interest: although the material cost is compa-
rable to that of the HPLC, the expenditures on reagents are much lower. Indeed, the
price of a capillary is much lower than that of a chromatography column, and the
volumes of buffer used are much lower, about 1000 times less [34].
4.2.1 Manual systems
4.2.1.1 Offer
Manual systems for native electrophoresis (on cellulose acetate and agarose gel)
or isoelectrofocusing offer the best acquisition possibility both in terms of cost and
operational constraints. Their limits both in the separation and in the identification
of hemoglobin variants will be used for the routine forms to be specified by the
customer (identification of the electrophoretic profile, identification of specific
variants).
The coupling of these methods to the reading system (densitometers) makes it
possible to quantify the separate variants. And from this point of view, agarose gel
electrophoresis offers better performance than cellulose acetate. On the other hand,
the reagents are in the form of combs which often require a minimum of seven
samples. Such a constraint requires, for economic reasons, to launch the samples in
series of seven, which requires a consequent sizing and proper holding wire.
4.2.1.2 Facilities
For native electrophoresis the system is usually composed of a current generator
and a migration tank. For isoelectrofocusing, the system consists of a stabilized
supply, an isoelectrofocusing, unit, and a circulating cryostat.
The devices typically contain conventional electronic parts and boards, used in
the manufacture of power generators. These components are often not complex,
and do not require advanced technical repair. In addition, it has been found that
when equipment actually meets ISO, FDA, or CE marking standards, it works well
and lasts for a long time.
4.2.1.3 Use
These systems can be used in very small laboratories, without large volume flow
of samples, for the screening of hemoglobinopathies, by planning a periodic opera-
tion. Indeed, the pre-analytical phase requires a lot of sample preparation time and
immobilizes the staff for quite a long time. They can also be used in medium
laboratories as a backup system.
The isoelectrofocusing system will be more targeted for newborn screening
because it allows for a good separation of the Hb F, Hb A, and Hb S fractions, which
assumes that the system is usually installed near a maternity ward.
10
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4.2.2 Semiautomatic systems
4.2.2.1 Offer
Semiautomatic systems for native electrophoresis on cellulose acetate or agarose
gel offer the possibility of processing large series of samples. Although the cost of
the system is still high for a large number of health facilities, the manual routine is
clearly improved. Semiautomatic systems (on cellulose acetate or agarose gel) are
embedded on compact systems generally comprising a migration and coloring
modules, which considerably reduce user handling.
The reading system, often equipped with advanced post-processing software, can
be incorporated or remote. Nevertheless, the results obtained show the same limits as
in the case of manual methods because the operating principles of the migration and
coloring units taken separately are the same as those of the manual system.
4.2.2.2 Facilities
The semiautomatic system is generally composed of a compact unit comprising a
thermoregulated migration module connected to a current generator and a fluidic
module for coloring migrated gels. Technologically, an intelligent electronic unit
manages the high voltage of the migration module, the fluidics of the coloring
module, and the application programs for the two modules.
Generally, devices typically contain conventional electronic parts and boards.
The process control is often ensured by position and temperature sensors. As their
complexity is not great, maintenance can be easily carried out by a duly trained
biomedical technician.
4.2.2.3 Use
These systems can equip medium-sized laboratories by planning either periodic
operation or continuous operation, depending on the flow of samples. They are
fairly widespread in the private laboratories which can obtain them and some public
hospital laboratories often on behalf of specific programs. User maintenance mon-
itoring must be ensured to guarantee proper functioning, and periodic annual
maintenance must be carried out, insured in accordance with the manufacturer’s
recommendations.
4.2.3 Automatic techniques
4.2.3.1 Offer
Automatic techniques (only capillary zone electrophoresis) are the best offer,
both in terms of flexibility of use and technical performance. Prices are still very
high for many customers in Africa. Nevertheless, a good expression of needs and
an adequate exploitation planning can allow a return on investment in an acceptable
time.
4.2.3.2 Facilities
These techniques are carried out on compact systems, generally comprising
capillaries at the ends plunging into reservoirs of buffer solution, themselves
connected to the current generator. The apparatus also includes a detection system,
most often a UV–visible spectrophotometer, linked to the wavelength of specific
absorption of hemoglobin at 415 nm.
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Migration
support
Advantages Disadvantages Systems Materials Maintenance
level
Constraints Average
cost (€)
Paper - Native electrophoresis
- Separation of amino acids and
peptides
- High electroendosmosis current
- Significant Joule effect
- Bad resolution
- Poor homogeneity
- Parasite adsorptions
Manual - Current generator - Low Good
grounding
- Migration tank - Free Free 7000
- Densitometer - Low Free
Cellulose
acetate
- Native electrophoresis
- More homogeneous than paper
- Separation of plasma and urine
proteins, lipoproteins,
hemoglobin, and isoenzymes
- High electroendosmosis currents
- Poor resolution
- Medium reproducibility
- The hemoglobins A2, C, E, and O migrate
in the same zone
- The hemoglobins S, D, and G migrate at
the same rate
- Long implementation
Manual - Current generator - Low Good
grounding
- Migration tank - Free Free 7000
- Densitometer - Low Free
Semiautomatic - Compact staining and
migration module and
densitometer (integrated or no)
- Medium
- Medium
- Steady
voltage
- Good
grounding
- Air-
conditioned
room
- Inverter
15,000
Agarose gel -Native electrophoresis
- Nonnative electrophoresis
- Limited electroendosmosis flow
- Improved resolution
- Very homogeneous
- Separation of Hb C from Hb E
and Hb O
- Separation of Hb S from Hb D
and Hb G
- No separation between
HB E and Hb O
- No separation between Hb D and Hb G
- Inaccurate for the quantification of
hemoglobin with low concentration (Hb
A2) and for the detection of variants with
fast migration (Hb H and Hb Bart’s)
- Long Implementation
Manual - Current generator -Low Good
grounding
- Migration tank -Free Free 7000
- Densitometer - Low Free
Semiautomatic - Compact staining and
migration module and
densitometer (integrated or no)
- Medium
- Medium
- Steady
stable
- Good
grounding
- Air-
conditioned
room
- Inverter
15,000
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Migration
support
Advantages Disadvantages Systems Materials Maintenance
level
Constraints Average
cost (€)
Semiautomatic -Isoelectrofocusing module - Medium - Steady
voltage
- Good
grounding
- Air-
conditioned
room
- Inverter
150,000
-Circulation cryostat - Medium - Steady
voltage
- Good
grounding
- Air-
conditioned
room
- Inverter
Liquid vein
(capillaries)
- Fast
- Precise quantification of
hemoglobin fractions
- Flexible (small and large series)
-High water quality
-Demanding environment
Automatic - Compact migration and
detection module
- High - Steady
voltage
- Good
grounding
- Air-
conditioned
room
- Inverter
- Water
quality
30,000
Table 1.
Summary table of different devices.
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More sophisticated technology includes a capillary thermoregulation system, a
control system comprising various sensors that manage optics, robotics, pneu-
matics, and detection, and a set of intelligent electronic cards capable of communi-
cating with each other. Unlike previous methods, this method allows both to launch
samples in an emergency without restriction and to process large series of samples.
In view of the complexity of its technology, management requires competent
personnel who are regularly trained by the manufacturer. Water quality and user
maintenance of equipment are of paramount importance to ensure the quality of
results. This assumes that the supplier provides user training for the best care.
4.2.3.3 Use
Thanks to their flexibility in the work organization, these automated systems can
equip laboratories with small volumes of samples, as well as those which process large
volumes. Indeed, there are small and large models of automata to cover all these
needs. Because of their high prices, these automata are acquired in public hospitals on
the basis of research projects and specific programs. Private clinics acquire them for
routine because of their performance. However they do have a few requirements that
must be observed: the operating environment must be less dusty, the quality of
electricity flawless, the quality of pure water, and regular maintenance.
We present in Table 1 a summary of different devices that we have reviewed.
5. Discussion on the choice to be made for equipment acquisition
For better use of data in Table 1, it will be broken down below with two sub-
sidiaries: Tables 2 and 3.
The information contained in Table 2 will highlight the performance of the
equipment according to different migration or embedded media available, while
those in Table 3 will compare the systems sold compared to hardware, installation
constraints, execution time, and cost.
A cursory reading shows that the most efficient migration support remains one of
the capillary methods (liquid vein): this support brings in itself the best return for the
resolution, reproducibility, discrimination, and quantification, while the parasitic
effects are almost nonexistent. But medical needs and health goals differ from one
level to another and do not require in all cases the acquisition of such technology.
For routine screening for sickle cell disease, for example, the performance of
migration on cellulose acetate amply suffices needs. This assumes that the precise
separation variants like Hb A2, Hb C, Hb E, and Hb O are not a need first. On the
other hand, as part of the requirements to cover, the effective separation of Hb S and
Hb C variant is needed, and migration on agarose gel will best meet this requirement.
If, during treatment, abnormal forms of hemoglobin are associated, then the
choice of medium will be directed towards agarose gel for a qualitative indication or
the liquid vein for a quantitative indication of Hb A2. Indeed, abnormally low Hb A
and abnormally high Hb A2 correlate with the presence of some abnormal forms of
hemoglobin (alpha or beta thalassemia, etc.).
If precise separation and precise quantification of the variants HbA2, Hb C, Hb E,
andHbOare required, then the liquid vein (capillary) support should be readily chosen.
Depending on work previously defined criteria, this table can guide the choice of
performance basis based migration media.
But the only performance criteria are not sufficient to make a choice of appro-
priate materials. It will also take into account industrial supply in terms of existing
14
Human Blood Group Systems
systems, the materials that make up, their costs, and maintenance requirements.
Below we provide a table that can guide us in assessing the choices to be made.
The line “migration support” is added in order to link Tables 2 and 3.
The analysis of the table shows that as the system moves from manual to fully
automated, the necessary hardware is gradually being integrated into a compact
module. From this point of view, this development provides an appreciable response
to the ergonomic problems that are becoming very frequent in laboratories.
On the other hand, we observe that the installation constraints are more
demanding when the analysis module becomes more compact. Indeed, in addition
to the quality of the electrical ground line and voltage which greatly affect the
operation of systems provided, the environment requires better temperature con-
trol (air conditioning), for example, besides the requirements of the water quality.
Performances Migration support
Paper Cellulose
acetate
Agarose
gel
Liquid
vein
Nonnative electrophoresis ✓ ✓
Native electrophoresis ✓ ✓ ✓ ✓
Separation of amino acids and peptides ✓ ✓ ✓ ✓
Homogeneity ✓
(poor)
✓ (medium) ✓ (good) ✓
Separation of plasma and urine proteins, lipoproteins,
hemoglobin, and isoenzymes
— ✓ ✓ ✓
Resolution ✓
(bad)
✓ (poor) ✓ ✓
Separation of Hb A2 from Hb C, Hb E, and Hb O — x (migrate in
the same area)
✓ ✓
Separation of Hb C from Hb E and Hb O — x ✓ ✓
Separation of Hb S and Hb from Hb D and G — x (migrate at
the same rate)
✓ ✓
Separation of Hb S and Hb O — x x ✓
Separation of Hb D and Hb G — x x ✓
Rapidity Low Good Good Fast
Quantification of hemoglobin with low concentration
(Hb A2)
— x x ✓
Detection of fast-migrating variants (Hb H, Hb Bart’s) — x x ✓
Precise quantification of hemoglobin fractions — x x ✓
Flexible (small and wide series) — x x ✓
Electroendosmosis current Very
high
High High High
Joule effect ✓ — — —
Pest adsorption ✓ x x x
Reproducibility — ✓ (medium) ✓ ✓
Water quality Normal Normal Normal High
Demanding environment Normal Normal Normal High
Table 2.
Performance comparison based on migration support.
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The time required to perform the analyses is a very important parameter in the
choice of equipment. On the one hand, it allows better management of the patient
queue, and on the other hand, it ensures the management of reagents and consum-
ables with a limited life. When the volume of samples to be treated in a routine
manner is small, manual systems are suitable for both patient satisfaction and
reactive management. If the volume of samples to be processed requires more than
1 day of work, the semiautomated system should be considered to resolve the
queue. Finally, if the volume of samples increases further, the fully automated
system will better meet expectations.
The management of reagents in the laboratory depends heavily on two impor-
tant parameters that should be noted: this is the expiry date and the stability time
after opening of the reagent. The expiry date indicated on the label is usually the
date after which the manufacturer no longer guarantees the validity of the results,
while the stability time after opening of the reagent indicates the period after which
the manufacturer no longer guarantees its reliability after the first use.
Since the stability time is shorter than the expiry date itself, it will be necessary
to ensure that each open reagent is consumed before that time. For example, the use
of a reagent that has a stability time of 60 days and can analyze 1000 samples in a
laboratory that receives only 10 samples per day is a waste. The use of this reagent
before maturity requires an average daily rate of 20 samples, considering that the
laboratory operates 6 days a week. Ten samples/day instead of 20 samples/day will
theoretically cause the damage of half the reagent.
The level of maintenance, and in turn cost, follows the same trend: more com-
pact system is provided and the higher level of maintenance.
Since the cost of acquiring systems increases with the complexity of the tech-
nology, it is important to ask good questions, find good answers, and make good
choices based on real needs, to achieve savings. As an example, is it necessary to
acquire a semiautomatic agarose gel system when, taking into account the medical
needs and the volume of samples to be treated, the manual system on agarose
gel support gives us satisfaction? Affirmative answer incurs an additional a
Systems
Manual Semiautomatic Automatic
Migration support -Paper
-Cellulose
acetate
-Agarose gel
Cellulose acetate
-Agarose gel
-Vein liquid (capillaries)
Equipment -Power
generator
-Tank migration
-Densitometer
-Module staining and
migration
-Densitometer (integrated
or not)
-Module compact migration and
detection
Installation
constraints
-Quality ground
line
-Quality voltage
-Quality ground line
-Quality voltage
-Quality air conditioning
-Quality ground line
-Quality voltage
-Quality air conditioning
-Quality of water
Execution time Très long Long Court
Acquisition cost
(en €)
7000 15,000 3000
Maintenance level Bas Moyen Haut
Table 3.
Comparison of systems in terms of hardware, installation constraints, acquisition cost, and maintenance level.
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non-justified expenditure of 8000€. Worse still, such equipment oversizing com-
promises a substantial depreciation because it will be under-utilized.
6. Conclusion
The management of any pathology implies the appropriate choice of techniques
and technologies. Indeed, beyond the medical needs that are priority, a control
equipment acquisition cost is one of the major parameters providing effective
support to strategies put in place.
Very often in sub-Saharan countries, the aspect of the consequent acquisition of
the necessary technology is not always thorough, and this can lead a poor quality of
reported results, the inaccessible test cost for the poorest people, and the delicate
operation of projects being implemented.
The choice of equipment performed after an objective needs analysis enables to
optimize the process of acquiring, to ensure the quality of reported results, and to
provide more accessible costs to target populations generally poor.
According to WHO recommendations, technology assessment, device evalua-
tion, needs planning, selection and acquisition, installation, commissioning, and
finally monitoring should be part of a successful acquisition procedure [35].
Such an approach should involve all stakeholders, namely, doctors, managers,
biomedical engineers, and users.
In the case of sickle cell anemia, the inventory of installed park shows that
beside manual methods, diagnostic techniques most common in the Democratic
Republic of the Congo and even in sub-Saharan Africa are phenotypic techniques.
These include the electrophoresis at different pH, the isoelectrofocusing, the capillary
electrophoresis, and the high-pressure liquid chromatography. The first three mentioned
are most used for their reliability, flexibility, ease of installation, and maintenance.
The prices of the equipment listed in the table remain indicative. We have taken
into account only good-quality equipment commonly used in the DR Congo and by
extension in other countries of sub-Saharan Africa.
For low-income countries, the costs of such facilities are still high overall.
Indeed, the increase in health expenditure, which represents 10% of the world’s
gross domestic product (GDP), is faster than the growth of the world economy.
According to a new World Health Organization report on global health spending, it
is increasing rapidly, particularly in low- and middle-income countries, where
spending is increasing at an average of 6% per year, compared to 4% in high-income
countries.
Health expenditure is assumed by governments, by individuals who pay for their
own care (out-of-pocket payments), and by other entities such as voluntary health
insurance schemes, employer-sponsored schemes, and nongovernmental organiza-
tions. On average, 51% of a country’s health expenditure is assumed by general
government and more than 35% by individuals in the form of direct expenditure.
One of the consequences of this situation is that every year 100 million people are
plunged into extreme poverty [36].
For the countries concerned, the acquisition of these health technologies
requires new upstream procurement strategies to meet acquisition and operating
costs. And from this point of view, some developed countries such as France are
now developing group procurement procedures in public hospitals.
According to a recent study conducted in the Democratic Republic of the Congo
on an investment in capillary electrophoresis equipment for a project on sickle cell
disease, this can contribute to improve quality and low cost of tests, if a complete
analysis of needs is carried out upstream.
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In this study, for an equipment activity extending over a period of 7 years, the
cost of acquisition and maintenance cost represent, respectively, 11.4% and 5.0% of
the total life cycle cost.
But when the activity of the same equipment is done over a period of 2 years, the
cost of acquisition and maintenance cost represent, respectively, 31.0% and 3.9% of
the total life cycle cost.
Added to this, for the same annual rate, the minimum unit test cost is € 3.9 for a
7-year activity cycle, whereas it costs € 5 if the activity cycle is reduced to 2 years
[37].
Therefore, it should be noted that when operating conditions remain the same,
amortization of equipment carried on shorter lead times significantly increases the
cost of the test at the expense of patients.
Even though this example only concerns electrophoresis capillary equipment,
extrapolating conclusions on agarose gel equipment is possible for the following
reasons: installation, operation, and maintenance are less demanding than for cap-
illary technology.
While sub-Saharan Africa is the most affected region in the world for sickle cell
disease, research and care are relatively slow.
At its 60th session held in Malabo from 30 August to 3 September 2010, the
WHO was already raising the option of a strategy for its African region. Nine years
after the effects are hardly noticeable.
The management improvement of this pathology solicits several challenges,
including the one concerning the technical platform necessary for diagnosis. The
costs of acquiring and operating equipment often require significant fundraising,
which is often lacking. The missing financial means are often one of the first
obstacles to the launching of the relevant programs.
The study mentioned above proves that it is possible to optimize the available
resources, however modest they may be, in order to obtain good and lasting results.
In the case of biomedical equipment, it is sufficient to involve the right people to
achieve the expected results. Policymakers in sub-Saharan African countries must
therefore integrate the skills of biomedical engineers into the design and start-up of
medical projects so that they, in turn, contribute effectively to improve the quality
of medical care populations.
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